Spots Global Cancer Trial Database for anlotinib hydrochloride capsule
Every month we try and update this database with for anlotinib hydrochloride capsule cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Anlotinib Hydrochloride Capsule Monotherapy and Combination Therapy Relapsed and Refractory Multiple Myeloma | NCT05549973 | Multiple Myelom... | Anlotinib Hydro... | 18 Years - | Institute of Hematology & Blood Diseases Hospital, China | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. | NCT05718167 | Advanced Squamo... | TQB2450 Anlotinib hydro... Tislelizumab in... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer | NCT04854668 | Metastatic Colo... | Anlotinib hydro... Bevacizumab Oxaliplatin Capecitabine | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | NCT04385550 | Advanced Gastri... | Anlotinib hydro... AK105 injection Paclitaxel inje... Docetaxel injec... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | NCT05193604 | Pancreatic Carc... | TQB2858 injecti... Anlotinib Hydro... Gemcitabine hyd... Paclitaxel for ... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma | NCT05994365 | Thyroid Neoplas... | Anlotinib Hydro... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. | NCT05481645 | Advanced Endome... Sarcoma of Uter... | TQB2450 injecti... Anlotinib Hydro... Carboplatin Inj... Paclitaxel Inje... Doxorubicin Hyd... Gemcitabine Hyd... Docetaxel injec... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx | NCT05068206 | Unresectable Me... | AK105 injection Anlotinib hydro... CapeOX Bevacizumab | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. | NCT05718167 | Advanced Squamo... | TQB2450 Anlotinib hydro... Tislelizumab in... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. | NCT05718167 | Advanced Squamo... | TQB2450 Anlotinib hydro... Tislelizumab in... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | NCT05494060 | Carcinoma Gastrointestina... Stomach Cancer Gastroesophagea... Digestive Syste... Gastric Cancer Gastrointestina... | Anlotinib hydro... Penpulimab Inje... XELOX | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma | NCT05121350 | Soft Tissue Sar... | Anlotinib hydro... Epirubicin Arotinib hydroc... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. | NCT05481645 | Advanced Endome... Sarcoma of Uter... | TQB2450 injecti... Anlotinib Hydro... Carboplatin Inj... Paclitaxel Inje... Doxorubicin Hyd... Gemcitabine Hyd... Docetaxel injec... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer | NCT04439890 | Advanced Non-sq... | Anlotinib hydro... Carboplatin inj... Pemetrexed diso... Placebo | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma | NCT05121350 | Soft Tissue Sar... | Anlotinib hydro... Epirubicin Arotinib hydroc... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | NCT05830500 | Medullary Thyro... | Anlotinib Hydro... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma | NCT05121350 | Soft Tissue Sar... | Anlotinib hydro... Epirubicin Arotinib hydroc... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
